References for: SUBJECT
Full identifier: http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT
Nanopublication | Part | Subject | Predicate | Object | Published By | Published On |
---|---|---|---|---|---|---|
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
the corticosteroid dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:16:56.165Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
the corticosteroid dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:16:54.908Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
the corticosteroid dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:16:53.585Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
the corticosteroid dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:16:52.286Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone ( Dex )
|
Eva Zegelaar
|
2021-12-16T20:14:14.585Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone ( Dex )
|
Eva Zegelaar
|
2021-12-16T20:14:13.151Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone ( Dex )
|
Eva Zegelaar
|
2021-12-16T20:14:11.701Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone ( Dex )
|
Eva Zegelaar
|
2021-12-16T20:14:10.255Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone ( Dex )
|
Eva Zegelaar
|
2021-12-16T20:14:08.786Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone ( Dex )
|
Eva Zegelaar
|
2021-12-16T20:14:07.312Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:13:14.136Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:13:12.541Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:13:10.605Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:12:31.441Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
Treatment with dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:12:30.122Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
the anti-inflammatory drugs methyl prednisolone and dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:12:28.814Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
the anti-inflammatory drugs methyl prednisolone and dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:12:27.327Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
the anti-inflammatory drugs methyl prednisolone and dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:12:25.815Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
the anti-inflammatory drugs methyl prednisolone and dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:12:24.218Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone ( Dex)-target complexes
|
Eva Zegelaar
|
2021-12-16T20:09:16.820Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone ( Dex)-target complexes
|
Eva Zegelaar
|
2021-12-16T20:09:14.970Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:08:55.863Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:08:54.102Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:08:52.563Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:08:50.799Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:08:49.021Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:08:47.405Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
After hypoxemia ( late dexamethasone group
|
Eva Zegelaar
|
2021-12-16T20:04:53.146Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
After hypoxemia ( late dexamethasone group
|
Eva Zegelaar
|
2021-12-16T20:04:51.797Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
After hypoxemia ( late dexamethasone group
|
Eva Zegelaar
|
2021-12-16T20:04:50.554Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
After hypoxemia ( late dexamethasone group
|
Eva Zegelaar
|
2021-12-16T20:04:49.299Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
After hypoxemia ( late dexamethasone group
|
Eva Zegelaar
|
2021-12-16T20:04:48.032Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
either dexamethasone or methylprednisolone
|
Eva Zegelaar
|
2021-12-16T20:04:46.741Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
either dexamethasone or methylprednisolone
|
Eva Zegelaar
|
2021-12-16T20:04:45.474Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
either dexamethasone or methylprednisolone
|
Eva Zegelaar
|
2021-12-16T20:04:44.115Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )
|
Eva Zegelaar
|
2021-12-16T20:04:29.879Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )
|
Eva Zegelaar
|
2021-12-16T20:04:28.665Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )
|
Eva Zegelaar
|
2021-12-16T20:04:27.422Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
Treatment of human peripheral blood mononuclear cells ( PBMCs ) with dexamethasone ( 100 nM ) or BAY11-7082 ( 1 μM )
|
Eva Zegelaar
|
2021-12-16T20:04:26.177Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
using the 8 mg dexamethasone administered orally before the procedure
|
Eva Zegelaar
|
2021-12-16T20:04:24.941Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
using the 8 mg dexamethasone administered orally before the procedure
|
Eva Zegelaar
|
2021-12-16T20:04:23.695Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
using the 8 mg dexamethasone administered orally before the procedure
|
Eva Zegelaar
|
2021-12-16T20:04:22.302Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
using the 8 mg dexamethasone administered orally before the procedure
|
Eva Zegelaar
|
2021-12-16T20:04:20.932Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
using the 8 mg dexamethasone administered orally before the procedure
|
Eva Zegelaar
|
2021-12-16T20:04:19.146Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
using the 8 mg dexamethasone administered orally before the procedure
|
Eva Zegelaar
|
2021-12-16T20:04:17.725Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:48.783Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:47.244Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:45.996Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:44.752Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:43.434Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:42.012Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:40.447Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:39.205Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:37.799Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:36.570Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:35.328Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
low-dose dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:03:34.074Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone-based regimens
|
Eva Zegelaar
|
2021-12-16T20:02:51.479Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone-based regimens
|
Eva Zegelaar
|
2021-12-16T20:02:49.469Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone-based regimens
|
Eva Zegelaar
|
2021-12-16T20:02:47.566Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone-based regimens
|
Eva Zegelaar
|
2021-12-16T20:02:45.911Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone-based regimens
|
Eva Zegelaar
|
2021-12-16T20:02:44.035Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone-based regimens
|
Eva Zegelaar
|
2021-12-16T20:02:42.575Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone-based regimens
|
Eva Zegelaar
|
2021-12-16T20:02:40.989Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:02:19.221Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:02:17.822Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:00:37.911Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T20:00:36.621Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T19:59:24.176Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T19:59:22.612Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T19:59:21.063Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T19:59:19.234Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T19:59:17.227Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T19:59:15.758Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T19:59:14.149Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
dexamethasone
|
Eva Zegelaar
|
2021-12-16T19:59:12.642Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:59:11.220Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:59:09.305Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:59:07.616Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:59:05.405Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:59:03.853Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:59:01.706Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:59:00.024Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:58.096Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:56.051Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:54.680Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:52.857Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:51.131Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:49.480Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:47.002Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:45.523Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:43.891Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:42.302Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:40.778Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:39.186Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:37.744Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:36.003Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:34.592Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:33.080Z
|
||
links a nanopublication to its provenance
http://www.nanopub.org/nschema#hasProvenance
provenance
|
SUBJECT
|
use of intravenous dexamethasone plus standard care compared with standard care alone
|
Eva Zegelaar
|
2021-12-16T19:58:31.278Z
|
||